American Journal of Kidney Diseases

Association of Family History of ESRD, Prevalent Albuminuria, and Reduced GFR With Incident ESRD

Published:November 14, 2011DOI:


      The contribution of albuminuria to the increased risk of incident end-stage renal disease (ESRD) in individuals with a family history of ESRD has not been well studied.

      Study Design

      Prospective cohort study.

      Study Setting & Participants

      We analyzed data for family history of ESRD collected from 19,409 participants of the Renal REGARDS (Reasons for Geographic and Racial Differences in Stroke) cohort study.


      Family history of ESRD was ascertained by asking “Has anyone in your immediate family ever been told that he or she had kidney failure? This would be someone who is on or had been on dialysis or someone who had a kidney transplant.”

      Study Outcomes

      Incidence rate for ESRD.


      Morning urine albumin-creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR). Incident cases of ESRD were identified through the US Renal Data System.


      A family history of ESRD was reported by 11.1% of participants. Mean eGFRs for those with and without a family history of ESRD were 87.5 ± 22.2 (SD) and 86.5 ± 19.3 mL/min/1.73 m2, respectively (P = 0.05) and the respective geometric mean ACRs were 12.2 and 9.7 mg/g (P < 0.001). ESRD incidence rates for those with and without a family history of ESRD were 244.3 and 106.1/100,000 person-years, respectively. After adjusting for age, sex, and race, the ESRD HR for those with versus those without a family history of ESRD was 2.13 (95% CI, 1.18-3.83). Adjustment for comorbid conditions and socioeconomic status attenuated this association (HR, 1.82; 95% CI, 1.00-3.28), and further adjustment for baseline eGFR and ACR completely attenuated the association between family history of ESRD and incident ESRD (HR, 1.12; 95% CI, 0.69-1.80).


      The report of a family history of ESRD was not validated.


      Family history of ESRD is common in older Americans and the increased risk of ESRD associated with a family history reflects lower GFR, higher albuminuria, and comorbid conditions.

      Index Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Kidney Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Freedman B.I.
        • Volkova N.V.
        • Satko S.G.
        • et al.
        Population-based screening for family history of end-stage renal disease among incident dialysis patients.
        Am J Nephrol. 2005; 25: 529-535
        • Freedman B.I.
        • Soucie J.M.
        • McClellan W.M.
        Family history of end-stage renal disease among incident dialysis patients.
        J Am Soc Nephrol. 1997; 8: 1942-1945
        • Tsai J.C.
        • Chen S.C.
        • Hwang S.J.
        • Chang J.M.
        • Lin M.Y.
        • Chen H.C.
        Prevalence and risk factors for CKD in spouses and relatives of hemodialysis patients.
        Am J Kidney Dis. 2010; 55: 856-866
        • Ferguson R.
        • Grim C.E.
        • Opgenorth T.J.
        A familial risk of chronic renal-failure among blacks on dialysis.
        J Clin Epidemiol. 1988; 41: 1189-1196
        • Hallan S.I.
        • Ritz E.
        • Lydersen S.
        • Romundstad S.
        • Kvenild K.
        • Orth S.R.
        Combining GFR and albuminuria to classify CKD improves prediction of ESRD.
        J Am Soc Nephrol. 2009; 20: 1069-1077
        • Iseki K.
        • Ikemiya Y.
        • Iseki C.
        • Takishita S.
        Proteinuria and the risk of developing end-stage renal disease.
        Kidney Int. 2003; 63: 1468-1474
        • Bergman S.
        • Key B.O.
        • Kirk K.A.
        • Warnock D.G.
        • Rostand S.G.
        Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease.
        Am J Kidney Dis. 1996; 27: 341-346
        • Bello A.K.
        • Peters J.
        • Wight J.
        • de Zeeuw D.
        • El Nahas M.
        • Inst E.K.
        A population-based screening for microalbuminuria among relatives of CKD patients: the Kidney Evaluation and Awareness Program in Sheffield (KEAPS).
        Am J Kidney Dis. 2008; 52: 434-443
        • Levey A.S.
        • Schoolwerth A.C.
        • Burrows N.R.
        • Williams D.E.
        • Stith K.R.
        • McClellan W.
        Comprehensive public health strategies for preventing the development, progression, and complications of CKD: report of an expert panel convened by the Centers for Disease Control and Prevention.
        Am J Kidney Dis. 2009; 53: 522-535
        • Black C.
        • Sharma P.
        • Scotland G.
        • et al.
        Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
        Health Technol Asses. 2010; 14: 1-184
        • Howard V.J.
        • Cushman M.
        • Pulley L.
        • et al.
        The Reasons for Geographic and Racial Differences in Stroke Study: objectives and design.
        Neuroepidemiology. 2005; 25: 135-143
        • Levey A.S.
        • Stevens L.A.
        • Schmid C.H.
        • et al.
        A new equation to estimate glomerular filtration rate.
        Ann Intern Med. 2009; 150: 604-612
        • McClellan W.M.
        • Satko S.G.
        • Gladstone E.
        • Krisher J.O.
        • Narva A.S.
        • Freedman B.I.
        Individuals with a family history of ESRD are a high-risk population for CKD: implications for targeted surveillance and intervention activities.
        Am J Kidney Dis. 2009; 53 (3): S100-S106
        • Jones C.A.
        • Francis M.E.
        • Eberhardt M.S.
        • et al.
        Microalbuminuria in the US population: Third National Health and Nutrition Examination Survey.
        Am J Kidney Dis. 2002; 39: 445-459
        • Narva A.S.
        • Briggs M.
        The National Kidney Disease Education Program: improving understanding, detection, and management of CKD.
        Am J Kidney Dis. 2009; 53 (3): S115-S120
        • Brown W.W.
        • Collins A.
        • Chen S.C.
        • et al.
        Identification of persons at high risk for kidney disease via targeted screening: the NKF Kidney Early Evaluation Program.
        Kidney Int. 2003; 63: 50-55
        • McClellan W.M.
        Epidemiology and risk factors for chronic kidney disease.
        Med Clin North Am. 2005; 89: 419-445
        • Freedman B.I.
        • Kopp J.B.
        • Langefeld C.D.
        • et al.
        The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans.
        J Am Soc Nephrol. 2010; 21: 1422-1426
        • Ned R.M.
        • Yesupriya A.
        • Imperatore G.
        • et al.
        Inflammation gene variants and susceptibility to albuminuria in the U.S. population: analysis in the Third National Health and Nutrition Examination Survey (NHANES III), 1991-1994.
        BMC Med Genet. 2010; 11: 155
        • Bostrom M.A.
        • Freedman B.I.
        The spectrum of MYH9-associated nephropathy.
        Clin J Am Soc Nephrol. 2010; 5: 1107-1113